Behrens, Annika S. https://orcid.org/0000-0003-3408-548X
Dietl, Anna K.
Adler, Werner
Geppert, Carol
Hartmann, Arndt
Knöll, Antje
Beckmann, Matthias W.
Mehlhorn, Grit
Koch, Martin C.
E. Schulmeyer, Carla
Seibold, A.
Gass, Paul
Stuebs, Frederik A.
Article History
Received: 17 January 2024
Accepted: 25 August 2024
First Online: 29 October 2024
Change Date: 15 March 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00404-025-07993-w
Declarations
:
: Paul Gass has received honoraria from Novartis, MSD, and AstraZeneca. None of the other authors has declared any conflicts of interest.
: Patient consent was not required for this retrospective study.
: Approval for the study was obtained from the ethics committee of the Faculty of Medicine at Friedrich Alexander University of Erlangen–Nuremberg (reference number: 245_19 Bc). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments, or comparable ethical standards.